139 related articles for article (PubMed ID: 26581002)
41. Pathology of the TSH receptor.
Duprez L; Parma J; Van Sande J; Rodien P; Sabine C; Abramowicz M; Dumont JE; Vassart G
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():295-302. PubMed ID: 10698593
[TBL] [Abstract][Full Text] [Related]
42. Response to "Long-term outcome of 'prophylactic therapy' for familial medullary thyroid cancer (MTC)".
Sadacharan D; Agarwal G
Surgery; 2011 Jun; 149(6):851. PubMed ID: 21621685
[No Abstract] [Full Text] [Related]
43. Paraganglioma syndrome and mutations of the SDHC gene.
Niemann S
JAMA; 2006 Feb; 295(6):625; author reply 625. PubMed ID: 16467230
[No Abstract] [Full Text] [Related]
44. Germline MUTYH (MYH) mutations in Portuguese individuals with multiple colorectal adenomas.
Isidro G; Laranjeira F; Pires A; Leite J; Regateiro F; Castro e Sousa F; Soares J; Castro C; Giria J; Brito MJ; Medeira A; Teixeira R; Morna H; Gaspar I; Marinho C; Jorge R; Brehm A; Ramos JS; Boavida MG
Hum Mutat; 2004 Oct; 24(4):353-4. PubMed ID: 15366000
[TBL] [Abstract][Full Text] [Related]
45. Familial thyroid carcinoma: a diagnostic algorithm.
Dotto J; Nosé V
Adv Anat Pathol; 2008 Nov; 15(6):332-49. PubMed ID: 18948764
[TBL] [Abstract][Full Text] [Related]
46. No evidence for large-scale germline genomic aberrations in hereditary bladder cancer patients with high-resolution array-based comparative genomic hybridization.
Kiemeney LA; Kuiper RP; Pfundt R; van Reijmersdal S; Schoenberg MP; Aben KK; Niermeijer MF; Witjes JA; Schoenmakers EF
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):180-3. PubMed ID: 16434610
[No Abstract] [Full Text] [Related]
47. Genetic hyperthyroidism: hyperthyroidism due to activating TSHR mutations.
Hébrant A; van Staveren WC; Maenhaut C; Dumont JE; Leclère J
Eur J Endocrinol; 2011 Jan; 164(1):1-9. PubMed ID: 20926595
[TBL] [Abstract][Full Text] [Related]
48. [Hereditary thyroid cancer].
Dralle H; Machens A; Lorenz K
Chirurg; 2008 Nov; 79(11):1017-28. PubMed ID: 18818894
[TBL] [Abstract][Full Text] [Related]
49. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.
Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C
Genes Chromosomes Cancer; 2002 Sep; 35(1):74-80. PubMed ID: 12203792
[TBL] [Abstract][Full Text] [Related]
50. Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney complex).
Stratakis CA; Jenkins RB; Pras E; Mitsiadis CS; Raff SB; Stalboerger PG; Tsigos C; Carney JA; Chrousos GP
J Clin Endocrinol Metab; 1996 Oct; 81(10):3607-14. PubMed ID: 8855810
[TBL] [Abstract][Full Text] [Related]
51. Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer.
Vriens MR; Suh I; Moses W; Kebebew E
Thyroid; 2009 Dec; 19(12):1343-9. PubMed ID: 20001717
[TBL] [Abstract][Full Text] [Related]
52. BRCA1 2080insA mutation in familial breast cancer.
Alansari AS; Al-Moundhri M; Al-Nabhani MM; Al-Zidjali SA
Breast Cancer Res Treat; 2009 Feb; 113(3):605-6. PubMed ID: 18340530
[No Abstract] [Full Text] [Related]
53. The Role of Hereditary Factors in Ovarian Carcinoma.
Schrader KA
Clin Obstet Gynecol; 2017 Dec; 60(4):728-737. PubMed ID: 28990986
[TBL] [Abstract][Full Text] [Related]
54. The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.
Oliveira MN; Hemerly JP; Bastos AU; Tamanaha R; Latini FR; Camacho CP; Impellizzeri A; Maciel RM; Cerutti JM
Thyroid; 2011 Sep; 21(9):975-85. PubMed ID: 21834681
[TBL] [Abstract][Full Text] [Related]
55. Hereditary breast cancer syndromes in a Turkish population. Results of molecular germline analysis.
Güran S; Ozet A; Dede M; Gille JJ; Yenen MC
Cancer Genet Cytogenet; 2005 Jul; 160(2):164-8. PubMed ID: 15993273
[TBL] [Abstract][Full Text] [Related]
56. PMS2 mutations in childhood cancer.
Bonthron DT; Hayward BE; De Vos M; Sheridan E
Gut; 2005 Dec; 54(12):1821. PubMed ID: 16284300
[No Abstract] [Full Text] [Related]
57. Germ-line mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms.
Malkin D; Friend SH; Li FP; Strong LC
N Engl J Med; 1997 Mar; 336(10):734. PubMed ID: 9045054
[No Abstract] [Full Text] [Related]
58. Uncommon association of cerebral meningioma, parathyroid adenoma and papillary thyroid carcinoma in a patient harbouring a rare germline variant in the CDKN1B gene.
Bugalho MJ; Domingues R
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26762354
[TBL] [Abstract][Full Text] [Related]
59. [Two patients with Muir-Torre syndrome].
Vermeer MH; Neering H; Menko FH
Ned Tijdschr Geneeskd; 1999 Sep; 143(39):1980. PubMed ID: 10610483
[No Abstract] [Full Text] [Related]
60. Brooke-Spiegler syndrome presenting multiple concurrent cutaneous and parotid gland neoplasms: cytologic findings on fine-needle sample and description of a novel mutation of the CYLD gene.
Malzone MG; Campanile AC; Losito NS; Longo F; Perri F; Caponigro F; Schiavone C; Ionna F; Maiello F; Martinuzzi C; Nasti S; Botti G; Fulciniti F
Diagn Cytopathol; 2015 Aug; 43(8):654-8. PubMed ID: 25995191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
